Transcription of the hly operon of transmissible plasmids in Escherichia coli is subject to a tight regulation which also involves various chromosomal genes, such as hha. We have identified a 200-bp region within the hlyC gene, designated hlyM, which modulates hemolysin expression. The deletion of hlyM increased the activity of hly::galK fusion 20-fold. hlyM does not contain any internal promoter, nor is it capable of acting in trans. Our data suggest that the chromosomal Hha protein interacts with hlyM in order to silence the hly promoter. In addition, hlyR, a positive activator of hemolysin expression, seems to suppress the modulatory effect dictated by the Hha protein on the hlyM region.
Synthesis and secretion of hemolysin are determined by the hly operon located either on the chromosome or on conjugative plasmids (10) . Transcription of the hly operon produces a major 4-kb hlyCA transcript and a minor 8-kb hlyCABD transcript (31) . The two transcripts initiate at the same promoter, located upstream of the hlyC gene (12, 31) . The minor transcript is thought to be produced by readthrough, or antitermination, at a Rho-independent transcriptional terminator located between hlyA and hlyB (15) . Similar patterns of expression have been reported for the leukotoxins of Pasteurella (27) and Actinobacillus (26) species.
In the case of the plasmid hly operons, a 600-bp sequence (hlyR) located 1.5 kb upstream of hlyC is known to increase hemolysin expression (29) . The primary mechanism by which hlyR exerts its action has been proposed to be antitermination at the hlyA-hlyB transcriptional terminator (15, 16) .
Hemolysin expression is a rather complex process in which chromosomal genes are involved as well. Three of them, tolC (30) , hha (9, 21) , and more recently sfrB (1), have been identified. The hha gene was identified during analysis of hemolysin expression in cells harboring the hemolytic recombinant plasmid pANN202-312, which contains the cluster hlyCABD from pHly152 but lacks hlyR. The absence of hlyR causes cells harboring it to show poor hemolysin expression. In contrast, hha cells containing pANN202-312 produce high amounts of external and internal hemolysin, at levels similar to those of cells harboring plasmid pANN202-312R, which contains hlyR (9) . The hha mutation was mapped at min 10.5 on the Escherichia coli chromosome (21) . We have shown that the main effect of the hha mutation on hemolysin expression is to increase the rate of transcription of the hlyCA genes (21), despite of the faster decay of the hlyCA mRNA (3). Interestingly, the hha mutation affected also the expression of other heterologous proteins cloned in E. coli (22) . The hha gene codes for an 8.6-kDa protein, the Hha protein (21) , which is highly homologous to the YmoA protein of Yersinia enterocolitica (7) . The YmoA protein is a temperature-dependent modulator of different virulence genes, and it has been suggested that it may have a role in DNA topology (5) . In fact, we have recently reported that the hha mutation increases hemolysin expression through changes in the DNA topology (3) . In this work, we describe a 220-bp DNA sequence within hlyC which modulates hly transcriptional expression possibly by its interaction with the Hha protein, either directly or through Hha interaction with some other protein(s).
Bacterial strains and plasmids. E. coli HB101 (2), MC1061 (4), 5K (14) , and Hha2 (9) have been described previously. Strain SUY-1 was constructed by P1vir transduction of the hha mutation from strain Hha2 to strain MC1061. Plasmids carrying transcriptional hly::galK fusions are pK0-1 (18) and pK0-2 (6) derivatives. Their physical maps are shown in Fig. 1 . pKL200, kindly provided by J. Grinsted, contains the galK gene under lac promoter control. Hemolytic plasmids pSU127 and pSU129 (see Fig. 3 ) are pUC derivatives (28) which contain the whole hly operon from pHly152. Plasmid pSU2968 (see Fig. 3 ) was constructed by deleting the 220-bp SmaI-BamHI fragment within hlyC in pSU129.
Galactokinase assays. Galactokinase assays were performed by the method of McKenney et al. (18) . Units are millimoles of galactose phosphate produced per minute per milliliter of culture (optical density at 600 nm of 1) per plasmid copy (25) . Plasmid copy number was determined by ␤-lactamase assay (17) . Each assay was performed at least three times.
Northern (RNA) blot analysis. Total RNA was extracted from exponentially growing cells by hot phenol as described previously (19) and separated in a 1.0% agarose gel containing morpholine propane sulfonic acid (MOPS) and 1.1 M formaldehyde. RNA was transferred to a nitrocellulose membrane (Schleicher & Schuell) with 20ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate). To generate antisense RNA probe, the 793-bp EcoRI-HindIII fragment internal to hlyA was subcloned into pSP65 (20) and digested with HindIII, producing a linear fragment to be used as a template for SP6 RNA polymerase. The in vitro transcription reactions were performed with a Riboprobe System II kit (Promega). Hybridization was performed as described previously (21) . The filter was then exposed to X-ray film. The band corresponding to the hlyCA transcript was excised from the filter, and the radioactivity was measured in a beta scintillation counter. The half-life of the hlyCA transcript was determined by extracting RNA at succeeding time intervals upon the addition of rifampin (200 g ml
Ϫ1
) and comparing relative levels by Northern blot hybridization.
RNase protection assay. Assays were performed essentially as described previously (20) . The DNA template for the in vitro transcription reactions was the 770-bp HincII-SmaI fragment containing the hly promoter. Approximately 0.5 g of the [␣-32 P]UTP-labelled RNA probe and 40 g of total cellular RNA were annealed. RNA hybrids were digested with RNase A (10 g/ml) and RNase T 1 (50 ng/ml), and protected fragments were analyzed on a 6% polyacrylamide-7 M urea gel. Radioactive fragments were visualized by autoradiography.
hly transcription is silenced by a DNA sequence within hlyC. To identify new regulatory elements within the hly operon that could be implicated in its own regulation, we assayed a series of transcriptional hly::galK fusions (Fig. 1) . The fusion containing the hly promoter and most of the hlyC gene (pSU134) had relatively low transcription activity (4%). As expected (29) , insertion of the 1.2-kb EcoRI-HindIII fragment, which includes hlyR, upstream of the HindIII site in IS2 (pSU2939) increased this low-level expression of galactokinase ninefold.
The higher level of ␣-hemolysin expression in cells carrying hlyR ϩ operons could be the result of an increase in the rate of transcriptional synthesis or, alternatively, of a stabilization of the transcripts. To distinguish between these two possibilities, we measured the stability of the major hlyCA mRNA in both an hlyR ϩ and an hlyR operon carried in high-copy-number plasmids (pSU127 and pSU129, respectively) (Fig. 2) . The half-lives of the hlyCA transcript were very similar in the two operons (21.5 min in hlyR ϩ and 20.2 min in hlyR), indicating that hlyR does not have a detectable effect on the stability of hlyCA mRNA. In addition, we found that hly operons lacking hlyR expressed 40-fold less hlyCA mRNA than did hlyR ϩ operons (Fig. 2) . According to this finding, E. coli strains carrying plasmid pSU127 produced more extracellular hemolysin than isogenic strains harboring plasmid pSU129 (Fig. 3B) , as expected from previous results (11, 29) . The data presented here suggest that the accumulation of the major hlyCA mRNA is independent of its stability and, furthermore, is a direct effect of hlyR on the transcription initiation. Given the low transcriptional expression of pSU134, we thought that it might be possible that a particular sequence(s) located downstream of the hly promoter was silencing expression from the promoter. Therefore, we constructed two shorter transcriptional fusions similar to pSU134 and pSU2939, but both lacking a 220-bp fragment from the BamHI restriction site within hlyC (Fig. 1, plasmids pSU137 and pSU2739) . Surprisingly, both fusions lead to an elevated level of transcription (87 and 78%, respectively), completely independent of hlyR. In fact, this level of expression is even twofold higher than of the hlyR ϩ fusion carried in pSU2939 (Fig. 1) . Apparently, the 220-bp DNA fragment between the SmaI and the BamHI sites within hlyC silences transcription from the hly promoter. We called this region hlyM. In addition, our results suggest that hlyM-mediated silencing is independent of hlyR, and thus the two mechanisms act independently.
To further confirm the silencing effect of hlyM, we tested a longer hly::galK fusion which extends from the HindIII restriction site in IS2 to the first HindIII restriction site in hlyA and includes the region containing the hly promoter and the whole hlyC gene (Fig. 1, pSU2969 ). This fusion gave the same lowlevel expression as pSU134, ruling out the possibility of a local phenomenon. Deletion of the SmaI-BamHI fragment in this fusion results in fourfold increase (Fig. 1, pSU2970) . Similarly, deletion of the SmaI-BamHI fragment in the hemolytic plasmid pSU129 produced a moderate increase in the levels of extracellular HlyA protein detected (Fig. 3B ). In agreement with this finding, the level of the hlyCA mRNA increased fourfold in those cells (Fig. 3C) . Although the increase upon deletion of the hlyM region in these cases was smaller than we expected, we believe that this might be due to the interruption of hlyC translation, causing the release of the RNA polymerase and decreasing the transcriptional expression beyond that point.
The effect of hlyM could be mediated by an antisense RNA, but we could not confirm its presence by primer extension analysis (data not shown). In addition, the transcriptional activity of hlyM assayed in both orientations (Fig. 1, pSU132 and pSU141) was very low, suggesting that it does not contain any internal promoter. hlyM was also fused downstream of the galK gene expressed from the lac promoter in order to investigate whether hlyM contains a transcriptional terminator (data not shown). The results of this experiment suggest that the effect of hlyM does not involve termination activity. On the other hand, hlyM did not have any modulatory effect in trans-complementation studies (data not shown). We conclude that although the hly promoter is expressed at low levels in wild-type hly operons lacking hlyR, the deletion of 220 bp within hlyC relieves the silencing of transcription, suggesting that the promoter itself is capable of high levels of transcription initiation.
The hha chromosomal mutation overcomes the silencing produced by hlyM. We previously showed that introduction of the hha chromosomal mutation increased the amount of both intracellular and extracellular hemolysin, even in hemolytic plasmids lacking hlyR (9, 21) . That finding suggested that Hha could interact with specific regions of the hly operon and thus regulate its expression. In fact, we reported that the effect of the hha mutation on DNA topology was more specific in the presence of the HindIII fragment which includes the hly promoter and the whole hlyC gene (3).
We assayed various hly::galK transcriptional fusions in isogenic pairs of hha ϩ and hha strains ( Table 1 ). The fusions containing either the hly promoter alone (pSU137) or both the hlyR and the hly promoter (pSU2739) showed the same highlevel expression in both hha ϩ and hha strains (Table 1) . However, the activity of the fusion containing hlyM as well (pSU134) was more than 18-fold higher in the hha mutant host than that in wild-type host ( Table 1) . The high activity measured in hha strains carrying hlyM ϩ fusions was independent of hlyR (Table 1) . Therefore, Hha appears to be necessary for maintaining a low basal level of hly expression in operons lacking hlyR. In order for it to act to silence the hly promoter, the hlyM region must be present.
We have investigated whether the original promoter was active in the hha mutant cells or, alternatively, some other promoter structure became active. We performed RNase protection assays to define the hly transcription start site in both wild-type and hha strains harboring either plasmid pANN202-312R (Fig. 4) or plasmid pANN202-312 (data not shown). The length of the fragment protected in all cases was the same and suggested that hly mRNA has its 5Ј end at a position located about 400 nucleotides upstream of the SmaI site within hlyC regardless the presence of the hha mutation. The potential mRNA 5Ј end corresponds to the promoter previously reported (31). These results exclude the possibility that the higher levels of hly transcription in the hha strain are due to the utilization of a different promoter and support the hypothesis that the Hha protein silences the transcription of the hly genes originated in the wild-type promoter.
Although we have reported that hha mutants show alterations in the level of plasmid DNA supercoiling (3), it is not yet clear what the molecular basis of the silencing is. Apparently silencing and relief of silencing can occur over an extended region downstream of the transcription start site, as has been described previously (24) . In addition, the data currently available suggest that the positive activator hlyR is sufficient to overcome the effect of Hha on hlyM, allowing a higher level of transcription initiation. Since hlyR does not seem to encode a protein, it might be a topological role for this region.
Observations on other operons which appears to be under histone protein control reveal some common characteristics. (i) A number of promoters appear to be expressed at low levels in wild-type strains but at much higher levels in histone mutant strains (13) . (ii) In at least some cases, deletion of DNA near the promoter relieves the silencing of transcription, increasing expression to that seen in the mutants, suggesting that the promoter itself is capable of high levels of transcription initiation (24) . (iii) For several promoters, a positive activator or other DNA-binding protein can overcome the silencing and allow high levels of transcription initiation (8, 23) .
The results presented here bring new information about how the transcriptional expression of the hly operon is regulated in E. coli and strongly support the idea that the Hha protein is a negative modulator of the hly expression, possibly through its interaction with hlyM. 
